Vaxcyte, Inc.

PCVX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001649094

SEC filings (opens in a new tab)

In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Vaxcyte, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of PCVX: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	223	2	251	+30
Shares	103.1M	227.2K	119.1M	+16.3M (+15.8%)
Value	$6.47B	$14.3M	$8.13B	+$1.67B (+25.9%)

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Vaxcyte, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to PCVX in Q1 2024
Institution	Shares	Value	% of portfolio
Paradigm Biocapital Advisors LP	1,239,995	$84.7M	2.98%
Avoro Capital Advisors LLC	575,000	$39.3M	0.46%
Maverick Capital LtdSuperinvestorMaverick Capital	355,131	$24.3M	0.47%
EcoR1 Capital, LLC	300,000	$20.5M	0.52%
Cercano Management LLC	272,151	$18.6M	0.52%
Saturn V Capital Management LLC	185,175	$12.6M	5.07%
Capstone Investment Advisors, LLC	109,389	$7.47M	0.14%
Banque Pictet & Cie SA	60,887	$4.16M	0.04%
First Light Asset Management, LLC	60,284	$4.12M	0.32%
Healthcare of Ontario Pension Plan Trust Fund	59,400	$4.06M	0.01%
Connor, Clark & Lunn Investment Management Ltd.	45,766	$3.13M	0.01%
EAM Investors, LLC	43,732	$2.99M	0.47%
ArrowMark Colorado Holdings LLC	40,000	$2.73M	0.03%
Twinbeech Capital LP	31,647	$2.16M	0.04%
Jump Financial, LLC	30,224	$2.06M	0.06%
EFG Asset Management (North America) Corp.	19,425	$1.33M	0.23%
Russell Investments Group, Ltd.	18,858	$1.29M	0.00%
Maven Securities LTD	15,000	$1.02M	0.06%
Schroder Investment Management Group	14,374	$981.9K	0.00%
Eisler Capital (US) LLC	10,454	$714.1K	0.24%
Calamos Advisors LLC	10,165	$694.4K	0.00%
Harvest Investment Services, LLC	8,663	$591.8K	0.24%
Harbor Capital Advisors, Inc.	8,193	$560.0K	0.07%
Bayesian Capital Management, LP	6,028	$411.8K	0.04%
Toroso Investments, LLC	5,928	$404.9K	0.01%
Engineers Gate Manager LP	5,554	$379.4K	0.01%
Pictet & Cie (Europe) SA	4,846	$331.0K	0.01%
O'Shaughnessy Asset Management, LLC	4,703	$321.3K	0.00%
Cetera Investment Advisers	4,480	$306.0K	0.00%
SG Americas Securities, LLC	4,359	$298.0K	0.00%
ClariVest Asset Management LLC	4,148	$283.4K	0.03%
Kennedy Capital Management, Inc.	3,770	$257.5K	0.01%
Mariner, LLC	3,690	$252.1K	0.00%
Crossmark Global Holdings, Inc.	3,137	$214.0K	0.00%
Ci Investments Inc.	3,054	$209.0K	0.00%
Belvedere Trading LLC	2,585	$176.6K	0.01%
Pacer Advisors, Inc.	589	$40.2K	0.00%
Leonteq Securities AG	537	$36.7K	0.00%
Catalyst Funds Management Pty Ltd	400	$27.3K	0.01%
Rise Advisors, LLC	229	$15.6K	0.01%
Citadel Advisors LLC	119	$8.13K	0.00%
Continuum Advisory, LLC	100	$6.56K	0.00%
J.Safra Asset Management Corp	81	$5.53K	0.00%
Meeder Asset Management Inc	62	$4.24K	0.00%
Quantbot Technologies LP	57	$3.89K	0.00%
Rothschild Investment LLC	10	$683	0.00%
Massmutual Trust Co FSB	7	$478	0.00%
Huntington National Bank	5	$342	0.00%

Sold out (18)

Institutions that held Vaxcyte, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of PCVX in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Vestal Point Capital, LP	525,000	$33.0M
Great Point Partners LLC	360,000	$22.6M
Marshall Wace, LLP	91,198	$5.73M
Laurion Capital Management LP	50,000	$3.14M
Cowen and Company, LLC	38,092	$2.39M
Point72 Asset Management, L.P.	30,155	$1.89M
Alyeska Investment Group, L.P.	25,000	$1.57M
Edgestream Partners, L.P.	17,706	$1.11M
J. Goldman & Co LP	17,694	$1.11M
Advisory Research Inc	17,461	$1.10M
Y-Intercept (Hong Kong) Ltd	12,859	$807.5K
Jefferies Financial Group Inc.	11,869	$745.4K
Ellsworth Advisors, LLC	8,060	$506.2K
Walleye Trading LLC	6,741	$423.3K
Captrust Financial Advisors	5,820	$365.5K
Oppenheimer Asset Management Inc.	3,198	$200.8K
EntryPoint Capital, LLC	932	$58.5K
Able Wealth Management LLC	46	$2.89K

Not filed for Q1 2024 yet (2)

Institutions that held Vaxcyte, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCVX in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Putnam Investments LLC	227,118	$14.3M
Baystate Wealth Management LLC	40	$2.51K